Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03620435
Title Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors McGill University Health Center
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab

Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.